Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prochlorperazine for Acute Mountain Sickness Prophylaxis
NCT06310642Phase 4Completed
- Sponsor
- CHRISTUS Health
- Start
- May 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of prochlorperazine in acute mountain sickness (AMS), sponsored by CHRISTUS Health. Started May 2021; status: completed.
02
Drugs
prochlorperazine
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on NCT06310642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06310642.